North America Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031
The North America Genomics In Cancer Care Market would witness market growth of 15.0% CAGR during the forecast period (2024-2031).
The US market dominated the North America Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $13,049.8 million by 2031. The Canada market is experiencing a CAGR of 17.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 16.5% during (2024 - 2031).
Genomics has revolutionized cancer care by offering insights into the genetic underpinnings of the disease, enabling more precise and personalized approaches to treatment. Genomics plays a crucial role in identifying rare genetic syndromes associated with increased cancer risk.
Additionally, by analyzing whole-genome or exome sequences, clinicians can identify mutations linked to rare inherited cancer syndromes, such as Li-Fraumeni syndrome or Lynch syndrome. Early identification of these syndromes allows for tailored screening and preventive measures for affected individuals and their families.
The growing incidence of cancer in Mexico drives the need for advanced diagnostic tools, including genomic technologies. These tools help in early cancer detection, identifying genetic mutations and biomarkers that can lead to more accurate and timely diagnoses. The increasing cancer burden encourages the expansion of genomic research initiatives in Mexico. Research institutions and universities may intensify their efforts to study cancer genomics, leading to the development of new diagnostic and therapeutic solutions and thus boosting the genomics market.
Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
- Instruments
- Consumables
- Services
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
- US
- Canada
- Mexico
- Rest of North America
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Genomics In Cancer Care Market, by Application
- 1.4.2 North America Genomics In Cancer Care Market, by Product
- 1.4.3 North America Genomics In Cancer Care Market, by Technology
- 1.4.4 North America Genomics In Cancer Care Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. North America Genomics In Cancer Care Market by Application
- 5.1 North America Diagnostics Market by Country
- 5.2 North America Personalized Medicine Market by Country
- 5.3 North America Drug Discovery & Development Market by Country
- 5.4 North America Research Market by Country
- Chapter 6. North America Genomics In Cancer Care Market by Product
- 6.1 North America Instruments Market by Country
- 6.2 North America Consumables Market by Country
- 6.3 North America Services Market by Country
- Chapter 7. North America Genomics In Cancer Care Market by Technology
- 7.1 North America PCR Market by Country
- 7.2 North America Genome Sequencing Market by Country
- 7.3 North America Microarrays Market by Country
- 7.4 North America Nuclei Acid Extraction & Purification Market by Country
- 7.5 North America Others Market by Country
- Chapter 8. North America Genomics In Cancer Care Market by Country
- 8.1 US Genomics In Cancer Care Market
- 8.1.1 US Genomics In Cancer Care Market by Application
- 8.1.2 US Genomics In Cancer Care Market by Product
- 8.1.3 US Genomics In Cancer Care Market by Technology
- 8.2 Canada Genomics In Cancer Care Market
- 8.2.1 Canada Genomics In Cancer Care Market by Application
- 8.2.2 Canada Genomics In Cancer Care Market by Product
- 8.2.3 Canada Genomics In Cancer Care Market by Technology
- 8.3 Mexico Genomics In Cancer Care Market
- 8.3.1 Mexico Genomics In Cancer Care Market by Application
- 8.3.2 Mexico Genomics In Cancer Care Market by Product
- 8.3.3 Mexico Genomics In Cancer Care Market by Technology
- 8.4 Rest of North America Genomics In Cancer Care Market
- 8.4.1 Rest of North America Genomics In Cancer Care Market by Application
- 8.4.2 Rest of North America Genomics In Cancer Care Market by Product
- 8.4.3 Rest of North America Genomics In Cancer Care Market by Technology
- Chapter 9. Company Profiles
- 9.1 Agilent Technologies, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Danaher Corporation (Beckman Coulter, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.6 SWOT Analysis
- 9.4 Abbott Laboratories
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 Bio-Rad laboratories, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Product Launches and Product Expansions:
- 9.5.6 SWOT Analysis
- 9.6 GE HealthCare Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
- 9.7 Quest Diagnostics Incorporated
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental Analysis
- 9.7.4 SWOT Analysis
- 9.8 Revvity, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
- 9.9 Eurofins Scientific SE
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 SWOT Analysis
- 9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Acquisition and Mergers:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook